Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 95

1.

ST6GAL1 negatively regulates monocyte transendothelial migration and atherosclerosis development.

Zhang J, Liu Y, Deng X, Chen L, Yang X, Yu C.

Biochem Biophys Res Commun. 2018 Jun 2;500(2):249-255. doi: 10.1016/j.bbrc.2018.04.053. Epub 2018 Apr 16.

PMID:
29654763
2.

Differential expression of ST6GAL1 in the tumor progression of colorectal cancer.

Zhang S, Lu J, Xu Z, Zou X, Sun X, Xu Y, Shan A, Lu J, Yan X, Cui Y, Yan W, Du Y, Gu J, Zheng M, Feng B, Zhang Y.

Biochem Biophys Res Commun. 2017 May 13;486(4):1090-1096. doi: 10.1016/j.bbrc.2017.03.167. Epub 2017 Apr 1.

PMID:
28377225
3.

The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.

Britain CM, Dorsett KA, Bellis SL.

J Biol Chem. 2017 Mar 17;292(11):4663-4673. doi: 10.1074/jbc.M116.763862. Epub 2017 Jan 30.

4.

Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.

Zhang X, Pan C, Zhou L, Cai Z, Zhao S, Yu D.

BMC Cancer. 2016 Dec 16;16(1):949.

5.

ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.

Wei A, Fan B, Zhao Y, Zhang H, Wang L, Yu X, Yuan Q, Yang D, Wang S.

Oncotarget. 2016 Oct 4;7(40):65374-65388. doi: 10.18632/oncotarget.11699.

6.

The role of DNA methylation in ST6Gal1 expression in gliomas.

Kroes RA, Moskal JR.

Glycobiology. 2016 Dec;26(12):1271-1283. Epub 2016 Aug 10.

PMID:
27510958
7.

ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.

Chen X, Wang L, Zhao Y, Yuan S, Wu Q, Zhu X, Niang B, Wang S, Zhang J.

Oncotarget. 2016 Aug 9;7(32):51955-51964. doi: 10.18632/oncotarget.10192.

8.

Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells.

Wang YC, Stein JW, Lynch CL, Tran HT, Lee CY, Coleman R, Hatch A, Antontsev VG, Chy HS, O'Brien CM, Murthy SK, Laslett AL, Peterson SE, Loring JF.

Sci Rep. 2015 Aug 25;5:13317. doi: 10.1038/srep13317.

9.

Knockdown of ST6Gal-I inhibits the growth and invasion of osteosarcoma MG-63 cells.

Meng Q, Ren C, Wang L, Zhao Y, Wang S.

Biomed Pharmacother. 2015 May;72:172-8. doi: 10.1016/j.biopha.2015.04.020. Epub 2015 May 8.

PMID:
26054692
10.

Epigenetic inactivation of ST6GAL1 in human bladder cancer.

Antony P, Rose M, Heidenreich A, Knüchel R, Gaisa NT, Dahl E.

BMC Cancer. 2014 Dec 2;14:901. doi: 10.1186/1471-2407-14-901.

11.

Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1.

Ma H, Cheng L, Hao K, Li Y, Song X, Zhou H, Jia L.

PLoS One. 2014 Jan 16;9(1):e85113. doi: 10.1371/journal.pone.0085113. eCollection 2014.

12.

ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.

Swindall AF, Londoño-Joshi AI, Schultz MJ, Fineberg N, Buchsbaum DJ, Bellis SL.

Cancer Res. 2013 Apr 1;73(7):2368-78. doi: 10.1158/0008-5472.CAN-12-3424. Epub 2013 Jan 28.

13.

Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression.

Villar-Portela S, Muinelo-Romay L, Cuevas E, Gil-Martín E, Fernández-Briera A.

Pathobiology. 2011;78(4):201-9. doi: 10.1159/000326768. Epub 2011 Jul 19.

14.

Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6-sialylated blood group type 2H (ST2H) antigen.

Korekane H, Matsumoto A, Ota F, Hasegawa T, Misonou Y, Shida K, Miyamoto Y, Taniguchi N.

J Biochem. 2010 Sep;148(3):359-70. doi: 10.1093/jb/mvq077. Epub 2010 Jul 23.

PMID:
20656882
15.

Synthesis and expression of CDw75 antigen in human colorectal cancer.

Costa-Nogueira C, Villar-Portela S, Cuevas E, Gil-Martín E, Fernández-Briera A.

BMC Cancer. 2009 Dec 10;9:431. doi: 10.1186/1471-2407-9-431.

16.

Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern.

Petit B, Parrens M, Soubeyran I, Costes-Martineau V, Gachard N, Boulin M, Laurent C, Marfak A, Labrousse F, Bordessoule D, Feuillard J.

Histopathology. 2009 Apr;54(5):626-31. doi: 10.1111/j.1365-2559.2009.03262.x. No abstract available.

PMID:
19413643
17.

Down-regulation of liver Galbeta1, 4GlcNAc alpha2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans.

Gong M, Castillo L, Redman RS, Garige M, Hirsch K, Azuine M, Amdur RL, Seth D, Haber PS, Lakshman MR.

Metabolism. 2008 Dec;57(12):1663-8. doi: 10.1016/j.metabol.2008.07.021.

PMID:
19013288
18.

[Combinatorial effects of ST6Gal I siRNA and antisense oligonucleotide-mediated gene silence on metastasis ability of cervical carcinoma cells].

Yuan TH, Li MY, Li WY, Li H, Jiang ZH.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Mar;38(2):217-21. Chinese.

PMID:
17441333
19.

Elevation of ST6Gal I activity in malignant and transitional tissue in human colorectal cancer.

Vázquez-Martín C, Gil-Martín E, Fernández-Briera A.

Oncology. 2005;69(5):436-44. Epub 2005 Nov 25.

PMID:
16319516
20.

Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.

Chiricolo M, Malagolini N, Bonfiglioli S, Dall'Olio F.

Glycobiology. 2006 Feb;16(2):146-54. Epub 2005 Sep 28.

PMID:
16192407

Supplemental Content

Support Center